Doxazosin Mesylate

   
Google
 
Web NewDrugInformation.com

Doxazosin Mesylate


Drug - Doxazosin Mesylate
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Doxazosin Mesylate
Multiple ingredients are in alphabetical order.

Strength - EQ 2MG BASE
The potency of the active ingredient(s), Doxazosin Mesylate. May repeat for multiple part products.

Applicant - CLONMEL HLTHCARE
The firm name holding legal responsibility for Doxazosin Mesylate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 076161
The FDA assigned number to Doxazosin Mesylate. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Doxazosin Mesylate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jun 10, 2004
The date Doxazosin Mesylate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Doxazosin Mesylate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Doxazosin Mesylate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Clonmel Healthcare Ltd
The full name of the firm holding legal responsibility for the new application of Doxazosin Mesylate.

Doxazosin Mesylate